Instinct Bio Returns to Profit and Grows Revenue Nearly 10% in Yen Terms in First Half of Fiscal 2026
TOKYO, JAPAN - October 16, 2026 ( NEWMEDIAWIRE ) - Instinct Bio Technical Company Holdings Inc. (Nasdaq: BIOT) (“BIOT” or the “Company”), a Japan-based developer, manufacturer and seller of stem-cell-based and regenerative-medicine-related cosmetics and health products, today announced unaudited results for the six months ended May 31, 2026 (“1H FY2026”) of Instinct Bio Technical Company Inc. and its four Japanese operating subsidiaries (the “Operating Group”), which became wholly owned subsidiaries of the Company on July 23, 2026. The interim financial statements, reviewed by Morison LC PLT, and management’s discussion and analysis are furnished to the SEC on Form 6-K today. Results exclude the Company’s predecessor, Relativity Holdings Inc., and business combination costs. Comparisons are with the six months ended May 31, 2025. 1H FY2026 Highlights Revenue of USD 1,142,598, up 4.7% (up 9.8% in yen terms, from JPY 163.7 million to JPY 179.8 million). OEM/ODM revenue (83.4% of total) up 6.5% and Value Village e-commerce revenue up 12.2%, both in yen terms. Gross margin of 72.6% (1H FY2025: 79.7%), reflecting a smaller inventory build, new imported purchases and higher manufacturing
Cancele cuando quiera · 99 CA$/mes
